FDA approves new, non-opioid painkiller Journavx
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
National Academies of Sciences%2c Engineering%2c and Medicine1d
New Report Finds Co-Prescribing Opioids and Benzodiazepines to Veterans at VHA from 2007 to 2019 Increased Their Risk of Death
A new congressionally mandated report examines how opioid and benzodiazepine prescribing between 2007 and 2019 impacted all-cause mortality among veterans treated at the VHA.
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
KHQ2d
Opioid crisis worsens in Spokane County with alarming overdose data
The opioid crisis in Spokane County is escalating, according to data presented by Dr. Veena Singh from the Spokane County ...
Psychology Today7d
Grading the Progress of National Initiatives on the Opioid Crisis
Two leading drug experts set out a road map to reverse the opioid epidemic in 2016. This is how we've progressed since then.
Washington Examiner6d
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and ...
Trump to meet Japan's Ishiba as China trade war simmers
U.S. President Donald Trump will meet Japanese Prime Minister Shigeru Ishiba for the first time on Friday as two allies wary ...